Vivos Inc (RDGL)

[DPep]

Hopefully Vivos will just have a partnership with a large firm to increase production and distribution, and not a buyout.
I am still uneasy about a buyout where I see a potential for the product to get squashed to protect other much more expensive and repetitive treatments. This product will need to be used.

I am not worried about a dollar value for a buyout since this would be a technology purchase and would need to be 1-2 billion. It also makes it easier to understand the market pricing until the FDA (or say Apple as an example) adopts your new tech as a standard. Share price is not moving until a deal is done.

Realistically this should jump to .41 ish near the application submission pre-approval and I will not be surprised if this shoots in the short term to $5 with approval.